Your browser doesn't support javascript.
loading
Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women.
Schoemaker, Minouk J; Nichols, Hazel B; Wright, Lauren B; Brook, Mark N; Jones, Michael E; O'Brien, Katie M; Adami, Hans-Olov; Baglietto, Laura; Bernstein, Leslie; Bertrand, Kimberly A; Boutron-Ruault, Marie-Christine; Chen, Yu; Connor, Avonne E; Dossus, Laure; Eliassen, A Heather; Giles, Graham G; Gram, Inger T; Hankinson, Susan E; Kaaks, Rudolf; Key, Timothy J; Kirsh, Victoria A; Kitahara, Cari M; Larsson, Susanna C; Linet, Martha; Ma, Huiyan; Milne, Roger L; Ozasa, Kotaro; Palmer, Julie R; Riboli, Elio; Rohan, Thomas E; Sacerdote, Carlotta; Sadakane, Atsuko; Sund, Malin; Tamimi, Rulla M; Trichopoulou, Antonia; Ursin, Giske; Visvanathan, Kala; Weiderpass, Elisabete; Willett, Walter C; Wolk, Alicja; Zeleniuch-Jacquotte, Anne; Sandler, Dale P; Swerdlow, Anthony J.
Afiliação
  • Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
  • Nichols HB; Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.
  • Wright LB; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
  • Brook MN; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
  • Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
  • O'Brien KM; Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC.
  • Adami HO; Department of Medical Epidemiology and Biostatistics (MEB), Karolinska Institutet, Stockholm, Sweden.
  • Baglietto L; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway.
  • Bernstein L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Bertrand KA; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA.
  • Boutron-Ruault MC; Slone Epidemiology Center at Boston University, Boston, MA.
  • Chen Y; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Connor AE; Department of Population Health and Perlmutter Cancer Center, New York University School of Medicine, New York, NY.
  • Dossus L; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Eliassen AH; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Giles GG; Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.
  • Gram IT; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Hankinson SE; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Kaaks R; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.
  • Key TJ; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Kirsh VA; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø (UiT), The Arctic University of Norway, Tromsø, Norway.
  • Kitahara CM; Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA.
  • Larsson SC; Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
  • Linet M; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Ma H; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Milne RL; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Ozasa K; Karolinska Institute, Institute of Environmental Medicine, Stockholm, Sweden.
  • Palmer JR; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Riboli E; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA.
  • Rohan TE; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.
  • Sacerdote C; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Sadakane A; Radiation Effects Research Foundation, Hiroshima, Japan.
  • Sund M; Slone Epidemiology Center at Boston University, Boston, MA.
  • Tamimi RM; School of Public Health, Imperial College, London, United Kingdom.
  • Trichopoulou A; Albert Einstein College of Medicine, Bronx, NY.
  • Ursin G; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Visvanathan K; Radiation Effects Research Foundation, Hiroshima, Japan.
  • Weiderpass E; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
  • Willett WC; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Wolk A; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Zeleniuch-Jacquotte A; Hellenic Health Foundation, Athens, Greece.
  • Sandler DP; Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
  • Swerdlow AJ; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Int J Cancer ; 147(5): 1306-1314, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32012248
ABSTRACT
Early-adulthood body size is strongly inversely associated with risk of premenopausal breast cancer. It is unclear whether subsequent changes in weight affect risk. We pooled individual-level data from 17 prospective studies to investigate the association of weight change with premenopausal breast cancer risk, considering strata of initial weight, timing of weight change, other breast cancer risk factors and breast cancer subtype. Hazard ratios (HR) and 95% confidence intervals (CI) were obtained using Cox regression. Among 628,463 women, 10,886 were diagnosed with breast cancer before menopause. Models adjusted for initial weight at ages 18-24 years and other breast cancer risk factors showed that weight gain from ages 18-24 to 35-44 or to 45-54 years was inversely associated with breast cancer overall (e.g., HR per 5 kg to ages 45-54 0.96, 95% CI 0.95-0.98) and with oestrogen-receptor(ER)-positive breast cancer (HR per 5 kg to ages 45-54 0.96, 95% CI 0.94-0.98). Weight gain from ages 25-34 was inversely associated with ER-positive breast cancer only and weight gain from ages 35-44 was not associated with risk. None of these weight gains were associated with ER-negative breast cancer. Weight loss was not consistently associated with overall or ER-specific risk after adjusting for initial weight. Weight increase from early-adulthood to ages 45-54 years is associated with a reduced premenopausal breast cancer risk independently of early-adulthood weight. Biological explanations are needed to account for these two separate factors.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Aumento de Peso / Pré-Menopausa Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Aumento de Peso / Pré-Menopausa Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article